|
US5583238A
(en)
|
1990-11-19 |
1996-12-10 |
G. D. Searle & Co. |
Method for making intermediates useful in synthesis of retroviral protease inhibitors
|
|
DK0727419T3
(en)
|
1992-12-29 |
2002-06-10 |
Abbott Lab |
Intermediates for the preparation of compounds that inhibit retroviral protease
|
|
US5543417A
(en)
|
1994-10-21 |
1996-08-06 |
Merck & Co., Inc. |
Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
|
|
US6037157A
(en)
|
1995-06-29 |
2000-03-14 |
Abbott Laboratories |
Method for improving pharmacokinetics
|
|
CN1212706A
(en)
|
1996-02-13 |
1999-03-31 |
阿克佐诺贝尔公司 |
Serine protease inhibitors
|
|
IL120310A
(en)
|
1996-03-01 |
2002-02-10 |
Akzo Nobel Nv |
Serine protease inhibitors and pharmaceutical compositions containing them
|
|
AU2429197A
(en)
|
1996-04-04 |
1997-10-29 |
Bristol-Myers Squibb Company |
Cephalosporin derivatives
|
|
DE19748470A1
(en)
|
1997-11-03 |
1999-05-06 |
Hoechst Schering Agrevo Gmbh |
Carbamoylphenylsulfonylureas, process for their preparation and their use as herbicides and plant growth regulators
|
|
US20050267148A1
(en)
|
1998-07-15 |
2005-12-01 |
Teijin Limited |
Benzimidazole derivative
|
|
TR200100047T2
(en)
|
1998-07-15 |
2001-10-22 |
Teijin Limited |
Thiobenzimidazole derivatives
|
|
CN1372566A
(en)
|
1999-08-04 |
2002-10-02 |
阿格罗尼制药公司 |
Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
|
|
PA8507801A1
(en)
|
1999-12-03 |
2002-08-26 |
Agouron Pharma |
ANTIPICORNAVIRAL COMPOUNDS AND COMPOSITIONS, THEIR PHARMACEUTICAL USES AND THE MATERIALS FOR SYNTHESIS
|
|
US7244721B2
(en)
|
2000-07-21 |
2007-07-17 |
Schering Corporation |
Peptides as NS3-serine protease inhibitors of hepatitis C virus
|
|
US7012066B2
(en)
|
2000-07-21 |
2006-03-14 |
Schering Corporation |
Peptides as NS3-serine protease inhibitors of hepatitis C virus
|
|
US7842727B2
(en)
|
2001-03-27 |
2010-11-30 |
Errant Gene Therapeutics, Llc |
Histone deacetylase inhibitors
|
|
TW200301079A
(en)
|
2001-12-21 |
2003-07-01 |
Syngenta Participations Ag |
Avermectin B1 derivatives having an aminosulfonyloxy substituent in the 4"-position
|
|
PE20030857A1
(en)
|
2002-01-23 |
2003-10-25 |
Schering Corp |
COMPOUNDS AS INHIBITORS OF THE PROTEASE SERINE NS3 OF THE HEPATITIS C VIRUS
|
|
GB0205165D0
(en)
|
2002-03-06 |
2002-04-17 |
Astrazeneca Ab |
Chemical compounds
|
|
DE60322857D1
(en)
|
2002-03-25 |
2008-09-25 |
Nippon Kayaku Kk |
NEW ALPHA-AMINO-N- (DIAMINOPHOSPHINYL) LACTAM DERIVATIVE
|
|
AR040126A1
(en)
|
2002-05-29 |
2005-03-16 |
Glaxo Group Ltd |
PHENYL SULFONYL COMPOUND, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE FOR THE PREPARATION OF A MEDICINAL PRODUCT
|
|
AR040149A1
(en)
|
2002-06-07 |
2005-03-16 |
Novartis Ag |
AMINO ACETONITRILE COMPOUNDS, A PROCESS FOR THE PREPARATION, COMPOSITION, AND USE OF THE COMPOUND
|
|
UA84404C2
(en)
|
2002-06-12 |
2008-10-27 |
Байоджен Айдек Ма Инк. |
Method of treating ischemia reperfusion injury using adenosine receptor antagonists
|
|
GB0220187D0
(en)
|
2002-08-30 |
2002-10-09 |
Novartis Ag |
Organic compounds
|
|
EP1572660B1
(en)
|
2002-12-20 |
2011-01-26 |
X-Ceptor Therapeutics, Inc. |
Isoquinolinone derivatives and their use as therapeutic agents
|
|
US7078419B2
(en)
|
2003-03-10 |
2006-07-18 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Cytokine inhibitors
|
|
WO2004093860A1
(en)
|
2003-04-21 |
2004-11-04 |
Pfizer Inc. |
Inhibitors of sars related coronavirus proteinase
|
|
US20040235952A1
(en)
|
2003-05-05 |
2004-11-25 |
Agouron Pharmaceuticals, Inc. |
Inhibitors of severe acute respiratory syndrome (SARS) 3C-like proteinase
|
|
SE0301320D0
(en)
|
2003-05-06 |
2003-05-06 |
Astrazeneca Ab |
Positive modulators of nicotinic acetylcholine receptors
|
|
JP2007527389A
(en)
|
2003-06-30 |
2007-09-27 |
メルク エンド カムパニー インコーポレーテッド |
Radioactive cannabinoid-1 receptor modulator
|
|
CA2536570A1
(en)
|
2003-08-26 |
2005-03-10 |
Schering Corporation |
Novel peptidomimetic ns3-serine protease inhibitors of hepatitis c virus
|
|
US20060014821A1
(en)
|
2003-08-27 |
2006-01-19 |
Agouron Pharmaceuticals, Inc. |
Inhibitors of SARS 3C like protease
|
|
WO2005023294A2
(en)
|
2003-09-05 |
2005-03-17 |
The General Hospital Corporation |
Polyacetal drug conjugates as release system
|
|
AU2004298498B2
(en)
|
2003-12-11 |
2008-09-11 |
Schering Corporation |
Inhibitors of hepatitis C virus NS3/NS4a serine protease
|
|
AU2004312547A1
(en)
|
2003-12-31 |
2005-07-21 |
Taigen Biotechnology |
Protease inhibitors
|
|
US7462594B2
(en)
|
2003-12-31 |
2008-12-09 |
Taigen Biotechnology Co., Ltd. |
Peptide-like compounds that inhibit coronaviral 3CL and flaviviridae viral proteases
|
|
CA2554771A1
(en)
|
2004-01-30 |
2005-08-18 |
Johns Hopkins University |
Nitroxyl progenitor compounds and methods of use
|
|
RU2006134002A
(en)
|
2004-02-27 |
2008-04-10 |
Шеринг Корпорейшн (US) |
NEW COMPOUNDS OPERATING AS NS3 SERIN PROTEASE INHIBITORS HEPATITIS C VIRUS
|
|
WO2005085242A1
(en)
|
2004-02-27 |
2005-09-15 |
Schering Corporation |
Novel ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus
|
|
TW200536528A
(en)
|
2004-02-27 |
2005-11-16 |
Schering Corp |
Novel inhibitors of hepatitis C virus NS3 protease
|
|
TWI314927B
(en)
|
2004-02-27 |
2009-09-21 |
Schering Corporatio |
Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease
|
|
US7816326B2
(en)
|
2004-02-27 |
2010-10-19 |
Schering Corporation |
Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease
|
|
WO2005113580A1
(en)
|
2004-05-21 |
2005-12-01 |
Pfizer Inc. |
Anticoronviral compounds and compositions, their pharmaceutical uses and materials for their synthesis
|
|
US20050288338A1
(en)
|
2004-06-24 |
2005-12-29 |
Wenqing Yao |
Amido compounds and their use as pharmaceuticals
|
|
US8680290B2
(en)
|
2004-09-03 |
2014-03-25 |
Syngenta Limited |
Isoxazoline derivatives and their use as herbicides
|
|
US7531548B2
(en)
|
2004-09-30 |
2009-05-12 |
Tibotec Pharmaceuticals Ltd |
HIV inhibiting 5-carbo- or heterocyclic substituted pyrimidines
|
|
AU2005288864B2
(en)
|
2004-09-30 |
2012-08-23 |
Janssen Sciences Ireland Uc |
HIV inhibiting 5-heterocyclyl pyrimidines
|
|
CN100363346C
(en)
*
|
2004-10-22 |
2008-01-23 |
清华大学 |
Small molecular inhibiting agent for coronavirus main proteinase, its preparation method and uses
|
|
CA2577588C
(en)
|
2004-10-29 |
2013-09-10 |
Tibotec Pharmaceuticals Ltd. |
Hiv inhibiting bicyclic pyrimidine derivatives
|
|
WO2006061714A2
(en)
|
2004-12-09 |
2006-06-15 |
Pfizer Inc. |
Anticoronaviral compounds and compositions, their pharmaceutical uses and materials for their synthesis
|
|
GB2422829A
(en)
|
2005-02-04 |
2006-08-09 |
Oxagen Ltd |
Pyrrolopyridines and their use in the treatment of diseases mediated by PGD2 at the CRTH2 receptor
|
|
GB2422831A
(en)
|
2005-02-04 |
2006-08-09 |
Oxagen Ltd |
Pyrrolopyridines and their use in the treatment of diseases mediated by PGD2 at the CRTH2 receptor
|
|
DE602006002887D1
(en)
|
2005-04-14 |
2008-11-06 |
Hoffmann La Roche |
TRICYCLIC AZOL DERIVATIVES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICAL AGENTS
|
|
WO2006108489A1
(en)
|
2005-04-14 |
2006-10-19 |
F. Hoffmann-La Roche Ag |
Aminopyrazole derivatives, their manufacture and use as pharmaceutical agents
|
|
US20060281689A1
(en)
|
2005-06-02 |
2006-12-14 |
Schering Corporation |
Method for modulating activity of HCV protease through use of a novel HCV protease inhibitor to reduce duration of treatment period
|
|
US20060276406A1
(en)
|
2005-06-02 |
2006-12-07 |
Schering Corporation |
Methods of treating hepatitis C virus
|
|
MX2007016064A
(en)
|
2005-06-16 |
2008-03-10 |
Novartis Ag |
Compositions and methods for viral inhibition.
|
|
US20090170846A1
(en)
|
2005-10-03 |
2009-07-02 |
Pfizer Inc |
Inhibitors of the hiv integrase enzyme
|
|
WO2007058832A2
(en)
|
2005-11-12 |
2007-05-24 |
Boehringer Ingelheim International Gmbh |
Pyrrolo (2, 3-b) pyridine derivatives useful as tec kinase inhibitors
|
|
DE102005055354A1
(en)
|
2005-11-21 |
2007-10-31 |
Merck Patent Gmbh |
Substituted 5-phenyl-3,6-dihydro-2-oxo-6H- [1,3,4] thiadiazines
|
|
BRPI0619955A2
(en)
|
2005-12-15 |
2011-10-25 |
Hoffmann La Roche |
tricyclic lactam derivatives, their production and their uses as pharmaceutical agents
|
|
DE102006012251A1
(en)
|
2006-03-15 |
2007-11-08 |
Grünenthal GmbH |
Substituted 4-aminoquinazoline derivatives and their use for the preparation of medicaments
|
|
US20080004306A1
(en)
|
2006-04-10 |
2008-01-03 |
Painceptor Pharma Corporation |
Compositions and methods for modulating gated ion channels
|
|
TW200815351A
(en)
|
2006-05-02 |
2008-04-01 |
Astrazeneca Ab |
Novel compounds
|
|
WO2008037266A1
(en)
|
2006-09-25 |
2008-04-03 |
Universite Libre De Bruxelles |
Inhibitors of conventional protein kinase c isozymes and use thereof for treating inflammatory diseases
|
|
US20100093738A1
(en)
|
2006-10-06 |
2010-04-15 |
Basf Se |
Fungicidal Compounds and Fungicidal Compositions
|
|
US20090137549A1
(en)
|
2006-11-09 |
2009-05-28 |
Paul John Edward |
Novel compounds useful for the treatment of degenerative & inflamatory diseases
|
|
MY155009A
(en)
|
2006-12-27 |
2015-08-28 |
Sanofi Aventis |
Cycloalkylamine substituted isoquinolone derivatives
|
|
JP5405316B2
(en)
|
2006-12-27 |
2014-02-05 |
サノフイ |
Cycloalkylamine substituted isoquinoline derivatives
|
|
JP5491871B2
(en)
|
2007-02-28 |
2014-05-14 |
アドビナス セラピュティックス プライベート リミテッド |
2,2,2-Trisubstituted acetamide derivatives as glucokinase activators, methods and pharmaceutical applications thereof
|
|
JP2008280339A
(en)
|
2007-04-12 |
2008-11-20 |
Sumitomo Chemical Co Ltd |
Hydrazide compound and agent comprising the same for controlling harmful arthropod
|
|
JP2008260716A
(en)
|
2007-04-12 |
2008-10-30 |
Sumitomo Chemical Co Ltd |
Hydrazide compound and harmful arthropod-controlling agent containing the same
|
|
AU2008256859A1
(en)
|
2007-05-24 |
2008-12-04 |
Memory Pharmaceuticals Corporation |
4' substituted compounds having 5-HT6 receptor affinity
|
|
CN101902912A
(en)
|
2007-11-06 |
2010-12-01 |
纳幕尔杜邦公司 |
Fungicidal amines
|
|
US10189803B2
(en)
|
2008-02-22 |
2019-01-29 |
Illinois Institute Of Technology |
Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
|
|
US9446995B2
(en)
|
2012-05-21 |
2016-09-20 |
Illinois Institute Of Technology |
Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
|
|
GB0808953D0
(en)
|
2008-05-16 |
2008-06-25 |
Shire Llc |
substituted quinazolines
|
|
GB0808967D0
(en)
|
2008-05-16 |
2008-06-25 |
Shire Llc |
Substitute quinazolines
|
|
GB0808951D0
(en)
|
2008-05-16 |
2008-06-25 |
Shire Llc |
Substituted quinazolines
|
|
GB0808947D0
(en)
|
2008-05-16 |
2008-06-25 |
Shire Llc |
Substituted quinazolines
|
|
GB0808952D0
(en)
|
2008-05-16 |
2008-06-25 |
Shire Llc |
Substituted quinazolines
|
|
GB0808950D0
(en)
|
2008-05-16 |
2008-06-25 |
Shire Llc |
Substituted quinazolines
|
|
AU2009251291B2
(en)
|
2008-05-30 |
2013-05-02 |
F. Hoffmann-La Roche Ag |
Purine PI3K inhibitor compounds and methods of use
|
|
WO2010014179A1
(en)
|
2008-07-31 |
2010-02-04 |
Duke University |
Photolabile caged transition metal complexes and methods of using the same
|
|
US20110312945A1
(en)
|
2008-10-01 |
2011-12-22 |
James Jia |
Crth2 modulators
|
|
WO2010042646A1
(en)
|
2008-10-10 |
2010-04-15 |
Amgen Inc. |
Aza- and diaza-phthalazine compounds as p38 map kinase modulators and methods of use thereof
|
|
WO2010042649A2
(en)
|
2008-10-10 |
2010-04-15 |
Amgen Inc. |
PHTHALAZINE COMPOUNDS AS p38 MAP KINASE MODULATORS AND METHODS OF USE THEREOF
|
|
WO2010075257A1
(en)
|
2008-12-22 |
2010-07-01 |
Chemocentryx, Inc. |
C5ar antagonists
|
|
WO2010111060A1
(en)
|
2009-03-23 |
2010-09-30 |
Merck Sharp & Dohme Corp. |
P2x3, receptor antagonists for treatment of pain
|
|
WO2010138706A1
(en)
|
2009-05-27 |
2010-12-02 |
Ptc Therapeutics, Inc. |
Methods for treating breast cancer
|
|
US8697662B2
(en)
|
2009-05-27 |
2014-04-15 |
Ptc Therapeutics, Inc. |
Methods for treating Kaposi sarcoma
|
|
US8703726B2
(en)
|
2009-05-27 |
2014-04-22 |
Ptc Therapeutics, Inc. |
Methods for treating prostate conditions
|
|
US20120157402A1
(en)
|
2009-05-27 |
2012-06-21 |
Liangxian Cao |
Methods for treating brain tumors
|
|
WO2010138695A1
(en)
|
2009-05-27 |
2010-12-02 |
Ptc Therapeutics, Inc. |
Methods for treating neurofibromatosis
|
|
WO2010144686A1
(en)
|
2009-06-10 |
2010-12-16 |
North Carolina State University |
Inhibition and dispersion of bacterial biofilms with benzimidazole derivatives
|
|
WO2011003932A2
(en)
|
2009-07-10 |
2011-01-13 |
Basf Se |
Method for the direct amination of hydrocarbons into amino hydrocarbons, including electrochemical separation of hydrogen
|
|
SG177709A1
(en)
|
2009-07-21 |
2012-02-28 |
Gilead Sciences Inc |
Inhibitors of flaviviridae viruses
|
|
CN102596959A
(en)
|
2009-07-31 |
2012-07-18 |
拜奥克里斯特制药公司 |
Pyrrolo [1, 2-b] pyridazine derivatives as JANUS kinase inhibitors
|
|
JP2011057661A
(en)
|
2009-08-14 |
2011-03-24 |
Bayer Cropscience Ag |
Pesticidal carboxamides
|
|
TW201124078A
(en)
|
2009-12-22 |
2011-07-16 |
Du Pont |
Fungicidal 2-(bicyclic aryloxy) carboxamides
|
|
PT2523951E
(en)
|
2010-01-15 |
2015-09-14 |
Gilead Sciences Inc |
Inhibitors of flaviviridae viruses
|
|
EP3219713A1
(en)
|
2010-01-15 |
2017-09-20 |
Gilead Sciences, Inc. |
Inhibitors of flaviviridae viruses
|
|
EP2539334A1
(en)
|
2010-02-25 |
2013-01-02 |
Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patiëntenzorg |
Process for the preparation of -acyloxy -formamido amides
|
|
WO2011132048A1
(en)
|
2010-04-19 |
2011-10-27 |
Glenmark Pharmaceutical S.A. |
Heteroaryl compounds as pde10a inhibitors
|
|
WO2011133659A2
(en)
|
2010-04-20 |
2011-10-27 |
Emory University |
Inhibitors of hif and angiogenesis
|
|
US9198891B2
(en)
|
2010-05-21 |
2015-12-01 |
New York University |
Method of treating cancer by inhibition of protein kinase-like endoplasmic reticulum protein kinase
|
|
WO2012022045A1
(en)
|
2010-08-20 |
2012-02-23 |
Hutchison Medipharma Limited |
Pyrrolopyrimidine compounds and uses thereof
|
|
BR112013005223A2
(en)
|
2010-09-03 |
2016-05-03 |
Bayer Ip Gmbh |
"Substituted fused pyrimidinones and dihydropyrimidinones."
|
|
WO2012058531A2
(en)
|
2010-10-29 |
2012-05-03 |
North Carolina State University |
Modulation of response regulators by imidazole derivatives
|
|
WO2012058173A1
(en)
|
2010-10-29 |
2012-05-03 |
Merck Sharp & Dohme Corp. |
Hiv integrase inhibitors
|
|
WO2012087372A1
(en)
|
2010-12-22 |
2012-06-28 |
E. I. Du Pont De Nemours And Company |
Fungicidal 2-(bicyclic aryloxy)carboxamides
|
|
WO2012125668A1
(en)
|
2011-03-17 |
2012-09-20 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
|
RU2013153588A
(en)
|
2011-05-04 |
2015-06-10 |
Мерк Шарп И Доум Корп. |
MEDICINES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PRODUCING THEM
|
|
KR20140041519A
(en)
|
2011-06-07 |
2014-04-04 |
다이닛본 스미토모 세이야꾸 가부시끼가이샤 |
Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof
|
|
CN102827073A
(en)
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
Therapeutically active compositions and application methods thereof
|
|
CN102838523A
(en)
|
2011-06-23 |
2012-12-26 |
南开大学 |
Anti-enterovirus 71 (EV71) valerolactam compounds, preparation method and uses thereof
|
|
JP6121658B2
(en)
|
2011-06-29 |
2017-04-26 |
大塚製薬株式会社 |
Therapeutic compounds and related methods of use
|
|
US8716297B2
(en)
|
2011-07-15 |
2014-05-06 |
Abbvie Inc. |
Chemical entities to be used for Wee1 inhibition for the treatment of cancer
|
|
EP2748137A1
(en)
|
2011-08-22 |
2014-07-02 |
Syngenta Participations AG |
Dihydrofuran derivatives as insecticidal compounds
|
|
US9474759B2
(en)
|
2011-09-27 |
2016-10-25 |
Kansas State University Research Foundation |
Broad-spectrum antivirals against 3C or 3C-like proteases of picornavirus-like supercluster: picornaviruses, caliciviruses and coronaviruses
|
|
CN103130710B
(en)
|
2011-11-29 |
2015-12-16 |
南开大学 |
Anti-enteric virus71 (EV71) hexanolactam aldehyde compound and its production and use
|
|
CN103145608B
(en)
|
2011-12-07 |
2015-09-02 |
南开大学 |
Anti-enteric virus71 (EV71) hexanolactam compounds and its production and use
|
|
US9643974B2
(en)
|
2011-12-12 |
2017-05-09 |
Bayer Intellectual Property Gmbh |
Amino-substituted imidazopyridazines
|
|
RU2669695C2
(en)
|
2011-12-22 |
2018-10-15 |
Конекшис Лайф Сайенсиз Пвт. Лтд. |
Cyclic amide derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase and uses thereof
|
|
RU2705577C2
(en)
|
2011-12-30 |
2019-11-08 |
Ханми Фарм. Ко., Лтд. |
THIENO[3,2-d]PYRIMIDINE DERIVATIVES WITH PROTEIN KINASE INHIBITORY ACTIVITY
|
|
US20150080381A1
(en)
|
2012-04-12 |
2015-03-19 |
Ironwood Pharmaceuticals, Inc. |
Methods of treating alopecia and acne
|
|
MX365776B
(en)
|
2012-04-20 |
2019-06-12 |
Kumiai Chemical Industry Co |
Alkylphenylsulphide derivative and pest control agent.
|
|
US9309284B2
(en)
|
2012-05-02 |
2016-04-12 |
Kansas State University Reasearch Foundation |
Macrocyclic and peptidomimetic compounds as broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, caliciviruses and coronaviruses
|
|
US20150110723A1
(en)
|
2012-05-31 |
2015-04-23 |
Emory University |
Quinazoline derivatives, compositions, and uses related thereto
|
|
US10314816B2
(en)
|
2012-06-08 |
2019-06-11 |
Wisconsin Alumni Research Foundation |
Antimicrobial compounds, compositions and methods of use thereof
|
|
RU2665462C2
(en)
|
2012-06-27 |
2018-08-30 |
Ф. Хоффманн-Ля Рош Аг |
5-azaindazole compounds and methods for use thereof
|
|
EP2733143A1
(en)
|
2012-11-14 |
2014-05-21 |
Laboratorios Del Dr. Esteve, S.A. |
Substituted pyrazolo[3,4-d]pyrimidine compounds, their preparation and use as sigma receptors ligands
|
|
WO2014078214A1
(en)
|
2012-11-15 |
2014-05-22 |
Merck Sharp & Dohme Corp. |
Azetidine benzimidazoles as pde10 inhibitors
|
|
JP2014133739A
(en)
|
2012-12-12 |
2014-07-24 |
Dainippon Sumitomo Pharma Co Ltd |
Pharmaceutical comprising indazole derivative or pyrrolopyridine derivative
|
|
ES2684776T3
(en)
|
2013-01-18 |
2018-10-04 |
Bristol-Myers Squibb Company |
Phthalazinones and isoquinolinones as ROCK inhibitors
|
|
WO2014172871A1
(en)
|
2013-04-25 |
2014-10-30 |
Syngenta Participations Ag |
Dihydrobenzofuran derivatives as insecticidal compounds
|
|
TWI646092B
(en)
|
2013-08-26 |
2019-01-01 |
拜耳作物科學股份有限公司 |
Compound with insecticidal activity
|
|
CN105722833A
(en)
|
2013-09-16 |
2016-06-29 |
巴斯夫欧洲公司 |
Fungicidal pyrimidine compounds
|
|
WO2015036059A1
(en)
|
2013-09-16 |
2015-03-19 |
Basf Se |
Fungicidal pyrimidine compounds
|
|
AU2014331111B2
(en)
|
2013-10-04 |
2018-05-31 |
Bayer Cropscience Aktiencesellschaft |
Use of substituted dihydro-oxindolyl sulfonamides, or the salts thereof, for increasing the stress tolerance of plants
|
|
WO2015081203A1
(en)
|
2013-11-26 |
2015-06-04 |
Incyte Corporation |
Bicyclic heterocycles as bet protein inhibitors
|
|
JP5542237B1
(en)
|
2013-11-28 |
2014-07-09 |
新日鉄住金エンジニアリング株式会社 |
Gas temperature control method for blast furnace gas dry dust collector and blast furnace gas dry dust collector
|
|
JP2017503809A
(en)
|
2014-01-09 |
2017-02-02 |
バイエル・ファルマ・アクティエンゲゼルシャフト |
Amide substituted imidazopyridazine
|
|
MX368101B
(en)
|
2014-01-22 |
2019-09-19 |
Nabriva Therapeutics Ag |
12-epi-pleuromutilins.
|
|
NO2699580T3
(en)
|
2014-01-24 |
2018-02-24 |
|
|
|
JP6295702B2
(en)
|
2014-02-14 |
2018-03-20 |
東洋インキＳｃホールディングス株式会社 |
Reactive monomer and polymerizable composition using the same
|
|
WO2015143653A1
(en)
|
2014-03-26 |
2015-10-01 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS,COMPOSITIONS AND METHODS THEREOF
|
|
WO2015155332A1
(en)
|
2014-04-11 |
2015-10-15 |
Boehringer Ingelheim International Gmbh |
Spiro[3h-indole-3,2'-pyrrolidin]-2(1h)-one derivatives and their use as mdm2-p53 inhibitors
|
|
CN105037367A
(en)
|
2014-04-18 |
2015-11-11 |
四川海思科制药有限公司 |
Amino six-membered ring derivative and application thereof in medicines
|
|
TW201623265A
(en)
|
2014-05-09 |
2016-07-01 |
奇尼塔公司 |
Anti-viral compounds, pharmaceutical compositions, and methods of use thereof
|
|
AU2015276537B2
(en)
|
2014-06-16 |
2019-03-14 |
Fundacion Para La Investigacion Medica Aplicada |
Novel compounds as dual inhibitors of histone methyltransferases and dna methyltransferases
|
|
EP2957561A1
(en)
|
2014-06-18 |
2015-12-23 |
Université Paris 6 Pierre et Marie Curie UPMC |
Novel fluoroquinolones and use thereof to treat bacterial infections
|
|
NZ729150A
(en)
|
2014-08-29 |
2018-02-23 |
Gilead Sciences Inc |
Antiretroviral agents
|
|
CN111303159A
(en)
|
2014-10-02 |
2020-06-19 |
豪夫迈·罗氏有限公司 |
Pyrazole carboxamide compounds for the treatment of diseases mediated by Bruton's Tyrosine Kinase (BTK)
|
|
CN105566321B
(en)
|
2014-10-29 |
2020-04-21 |
广东东阳光药业有限公司 |
Heteroaromatic compounds and their use in medicine
|
|
JP6695875B2
(en)
|
2014-11-20 |
2020-05-20 |
カウンシル・オブ・サイエンティフィック・アンド・インダストリアル・リサーチ |
Novel 1,3,5-triazine PI3K inhibitor as anticancer agent and method for producing the same
|
|
WO2016123576A1
(en)
|
2015-01-30 |
2016-08-04 |
Lieber Institute For Brain Development |
Comt inhibiting methods and compositions
|
|
GB201501870D0
(en)
|
2015-02-04 |
2015-03-18 |
Cancer Rec Tech Ltd |
Autotaxin inhibitors
|
|
GB201502045D0
(en)
|
2015-02-06 |
2015-03-25 |
Ocado Innovation Ltd |
Device and method for purchasing goods and services
|
|
US9409872B1
(en)
|
2015-02-16 |
2016-08-09 |
Mark Quang Nguyen |
Fumarate compounds, pharmaceutical compositions thereof, and methods of use
|
|
MA41551A
(en)
|
2015-02-20 |
2017-12-26 |
Incyte Corp |
BICYCLIC HETEROCYCLES USED AS FGFR4 INHIBITORS
|
|
WO2016204816A1
(en)
|
2015-06-15 |
2016-12-22 |
Ruckus Wireless, Inc. |
Operator formed network consortiums
|
|
GB2548542A
(en)
|
2015-06-16 |
2017-09-27 |
Redx Pharma Plc |
Compounds
|
|
FR3037955B1
(en)
|
2015-06-25 |
2017-08-18 |
Univ Nantes |
POLYDENTATE LIGANDS AND METAL COMPLEXES
|
|
EP3328859B1
(en)
|
2015-07-30 |
2020-06-03 |
Boehringer Ingelheim International GmbH |
3-((4-isoquinolin-3-yl)methyl)-1h-imidazo[4,5-c]pyridin-2(3h)-one derivatives and related compounds as inhibitors of replication of the respiratory syncytial virus (rsv)
|
|
JP6602470B2
(en)
|
2015-10-09 |
2019-11-06 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Spiro [3H-indole-3,2'-pyrrolidin] -2 (1H) -one compounds and derivatives as MDM2-P53 inhibitors
|
|
TW201730190A
(en)
|
2015-12-24 |
2017-09-01 |
Genentech Inc |
TDO2 inhibitors
|
|
CN106928206B
(en)
*
|
2015-12-31 |
2022-02-18 |
中国科学院上海药物研究所 |
Aldehyde compound and its preparation method and use
|
|
JP6806413B2
(en)
|
2016-02-03 |
2021-01-06 |
塩野義製薬株式会社 |
Polycyclic pyridone derivatives and their prodrugs
|
|
WO2017155816A1
(en)
|
2016-03-09 |
2017-09-14 |
Merck Sharp & Dohme Corp. |
Quinazoline compounds useful as m1 receptor positive allosteric modulators
|
|
US10166236B2
(en)
|
2016-03-21 |
2019-01-01 |
Perlara Pbc |
Pharmaceutical formulations comprising substituted pyrazolo[5,1-c]pyrido[4,3-e][1,2,4]triazines for treating lysosomal storage disorders
|
|
US9975885B2
(en)
|
2016-04-28 |
2018-05-22 |
Purdue Research Foundation |
Broad-spectrum non-covalent coronavirus protease inhibitors
|
|
TW201808888A
(en)
|
2016-05-05 |
2018-03-16 |
嘉來克生命科學有限責任公司 |
Modulators of the integrated stress pathway
|
|
TW201808903A
(en)
|
2016-05-05 |
2018-03-16 |
嘉來克生命科學有限責任公司 |
Modulators of the integrated stress pathway
|
|
TW202304851A
(en)
|
2016-05-05 |
2023-02-01 |
美商嘉來克生命科學有限責任公司 |
Modulators of the integrated stress pathway
|
|
WO2017197377A1
(en)
|
2016-05-13 |
2017-11-16 |
Emory University |
Peptidomimetics for the treatment of norovirus infection
|
|
CN107459511B
(en)
|
2016-06-02 |
2020-05-29 |
南开大学 |
Anti-enterovirus 71(EV71) 4-iminooxazolidine-2-ketone compound and preparation method and application thereof
|
|
US20170355708A1
(en)
|
2016-06-09 |
2017-12-14 |
Cadent Therapeutics, Inc. |
Potassium channel modulators
|
|
WO2017222935A1
(en)
|
2016-06-20 |
2017-12-28 |
Kansas State University Research Foundation |
Small molecule therapeutic inhibitors against picornaviruses, caliciviruses, and coronaviruses
|
|
JP7061993B2
(en)
|
2016-07-08 |
2022-05-02 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
Tyrosine kinase inhibitor
|
|
WO2018015818A2
(en)
|
2016-07-15 |
2018-01-25 |
Lifesci Pharmaceuticals, Inc. |
Therapeutic inhibitory compounds
|
|
WO2018023054A1
(en)
|
2016-07-28 |
2018-02-01 |
Kansas State University Research Foundation |
Protease transition state inhibitor prodrugs
|
|
TW201817714A
(en)
|
2016-08-30 |
2018-05-16 |
英商葛蘭素史密斯克藍智慧財產權有限公司 |
Compounds that inhibit 3C and 3CL proteases and methods of use thereof
|
|
CN108069984B
(en)
|
2016-11-18 |
2021-02-05 |
沈阳中化农药化工研发有限公司 |
Substituted five-membered heterocyclic compound containing pyrimido ring and preparation method and application thereof
|
|
WO2018108627A1
(en)
|
2016-12-12 |
2018-06-21 |
Bayer Cropscience Aktiengesellschaft |
Use of substituted indolinylmethyl sulfonamides, or the salts thereof for increasing the stress tolerance of plants
|
|
EP3342779A1
(en)
|
2016-12-27 |
2018-07-04 |
Zedira GmbH |
Inhibitors of transglutaminases
|
|
US20180289676A1
(en)
|
2017-03-30 |
2018-10-11 |
Saint Louis University |
Compounds and methods targeting gper in cancer
|
|
CN108690043B
(en)
|
2017-04-11 |
2019-10-18 |
东莞东阳光科研发有限公司 |
Quinoline derivatives and its preparation method and application
|
|
EP3630775B1
(en)
|
2017-05-31 |
2022-12-14 |
ChemoCentryx, Inc. |
6-5 FUSED RINGS AS C5a INHIBITORS
|
|
EP3642187A1
(en)
|
2017-06-19 |
2020-04-29 |
Basf Se |
2-[[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]aryloxy](thio)acetamides for combating phytopathogenic fungi
|
|
JP2020152641A
(en)
|
2017-07-07 |
2020-09-24 |
国立研究開発法人理化学研究所 |
Novel compound having lysine-specific demethylating enzyme 1 inhibitory activity, method for producing the same, and use of the same
|
|
WO2019068726A1
(en)
|
2017-10-02 |
2019-04-11 |
Scientist Of Fortune S.A. |
Cellular transport system for transferring a sulfonic acid construct carrying a cargo into the cytoplasm of a cell
|
|
WO2019075386A1
(en)
|
2017-10-13 |
2019-04-18 |
The Regents Of The University Of California |
Mtorc1 modulators
|
|
WO2019086474A1
(en)
|
2017-10-31 |
2019-05-09 |
Syngenta Participations Ag |
Pesticidally active mesoionics heterocyclic compounds
|
|
WO2019089412A1
(en)
|
2017-11-01 |
2019-05-09 |
Merck Sharp & Dohme Corp. |
Novel substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (ido) inhibitors
|
|
WO2019104070A1
(en)
|
2017-11-21 |
2019-05-31 |
Nanostring Technologies, Inc. |
O-nitrobenzyl photocleavable bifunctional linker
|
|
US20200305429A1
(en)
|
2017-11-23 |
2020-10-01 |
Basf Se |
Herbicidal phenylethers
|
|
WO2019129121A1
(en)
|
2017-12-28 |
2019-07-04 |
Rpxds Co., Ltd |
Derivatives of phenylmethanone as fto inhibitors
|
|
CN109988109B
(en)
|
2017-12-29 |
2020-12-29 |
广东东阳光药业有限公司 |
Amine compound for inhibiting SSAO/VAP-1 and application thereof
|
|
GB201801355D0
(en)
|
2018-01-26 |
2018-03-14 |
Enterprise Therapeutics Ltd |
Compounds
|
|
US11884645B2
(en)
|
2018-03-02 |
2024-01-30 |
Inflazome Limited |
Sulfonyl acetamides as NLRP3 inhibitors
|
|
US20190282703A1
(en)
|
2018-03-13 |
2019-09-19 |
Mavupharma, Inc. |
Ectonucleotide pyrophosphatase-phosphodiesterase (enpp) conjugates and uses thereof
|
|
EP3775186A4
(en)
|
2018-03-30 |
2022-01-05 |
AbbVie Inc. |
Ectonucleotide pyrophosphate-phosphodiesterase (enpp) conjugates and uses thereof
|
|
WO2019201432A1
(en)
|
2018-04-17 |
2019-10-24 |
Zedira Gmbh |
Inhibitors of blood coagulation factor xiii
|
|
WO2019204816A1
(en)
|
2018-04-20 |
2019-10-24 |
Virginia Tech Intellectual Properties, Inc. |
Imidazopyridines useful as mitochondrial uncouplers
|
|
CN110054596B
(en)
|
2018-05-29 |
2023-03-31 |
沈阳化工大学 |
Substituted oxadiazole compound and application thereof
|
|
WO2019232245A1
(en)
|
2018-06-01 |
2019-12-05 |
The Regents Of The University Of California |
A method for fluorinated ring-opening of a substrate
|
|
EP3820500A4
(en)
|
2018-07-13 |
2022-04-13 |
Teqla Therapeutics, Inc. |
Use of bcl6 inhibitors for treating autoimmune diseases
|
|
RU2761824C2
(en)
|
2018-08-03 |
2021-12-13 |
Закрытое Акционерное Общество "Биокад" |
Cdk8/19 inhibitors
|
|
CN110818691A
(en)
|
2018-08-09 |
2020-02-21 |
中国科学院上海药物研究所 |
Ketoamide compound and preparation method, pharmaceutical composition and application thereof
|
|
WO2020037166A1
(en)
|
2018-08-16 |
2020-02-20 |
Cornell University |
Rhenium complexes and methods of use for treating cancer
|
|
CA3110877A1
(en)
|
2018-08-27 |
2020-03-05 |
Spinogenix, Inc. |
Fascin binding compounds for spinogenesis
|
|
US10696659B2
(en)
|
2018-11-21 |
2020-06-30 |
Accutar Biotechnology Inc. |
Compounds having estrogen receptor alpha degradation activity and uses thereof
|
|
EP3656762A1
(en)
|
2018-11-26 |
2020-05-27 |
Instituto Biomar S.A. |
Compounds for the treatment of nf-kb-related diseases or disorders
|
|
CA3123902A1
(en)
|
2019-01-03 |
2020-07-09 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Methods and materials for increasing transcription factor eb polypeptide levels
|
|
EP3927433A1
(en)
|
2019-02-18 |
2021-12-29 |
Genentech, Inc. |
Pyrido-pyrimidinyl compounds and methods of use
|
|
WO2020169682A1
(en)
|
2019-02-19 |
2020-08-27 |
Yncrea Hauts De France |
Hydrazide derivatives and their specific use as antibacterial agents by controlling acinetobacter baumannii bacterium
|
|
CN110105348A
(en)
|
2019-03-08 |
2019-08-09 |
南开大学 |
The preparation and purposes of novel michael acceptor class enteric virus71 type inhibitor
|
|
CN113518779B
(en)
|
2019-03-28 |
2024-03-15 |
江苏恒瑞医药股份有限公司 |
Thieno heterocyclic derivative, preparation method and medical application thereof
|
|
AU2020289560A1
(en)
|
2019-06-05 |
2021-12-23 |
Emory University |
Peptidomimetics for the treatment of coronavirus and picornavirus infections
|
|
KR20220151038A
(en)
*
|
2020-03-31 |
2022-11-11 |
피닉스 바이오테크놀러지 인코포레이티드. |
Compositions for preventing coronavirus infection
|
|
CR20210563A
(en)
*
|
2020-04-05 |
2022-01-24 |
Pfizer |
Compounds and methods for the treatment of covid-19
|
|
EP4132944A1
(en)
*
|
2020-04-10 |
2023-02-15 |
Cocrystal Pharma, Inc. |
Inhibitors of norovirus and coronavirus replication
|
|
US11124497B1
(en)
|
2020-04-17 |
2021-09-21 |
Pardes Biosciences, Inc. |
Inhibitors of cysteine proteases and methods of use thereof
|
|
KR20230040386A
(en)
|
2020-06-09 |
2023-03-22 |
파르데스 바이오사이언시스, 인크. |
Inhibitors of cysteine proteases and methods of use thereof
|
|
US11174231B1
(en)
|
2020-06-09 |
2021-11-16 |
Pardes Biosciences, Inc. |
Inhibitors of cysteine proteases and methods of use thereof
|
|
JP2023530267A
(en)
|
2020-06-10 |
2023-07-14 |
アリゴス セラピューティクス インコーポレイテッド |
Antiviral compounds for treating coronavirus, picornavirus and norovirus infections
|
|
CN116348477A
(en)
|
2020-07-20 |
2023-06-27 |
英安塔制药有限公司 |
Functionalized peptides as antiviral agents
|